Infectious Agents and Cancer

Table 2 Plating and Replating of lung and spleen for P-MAPA, MXF and MXF + P-MAPA antimycobacterial activities

From: Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer

Compounds	Tissues
	Lung				Spleen				Spleen Replate
	Mean CFU	log₁₀ prot	SEM	n	Mean CFU	log₁₀ prot	SEM	n	Mean CFU	log₁₀prot	SEM	n
Untreated Ctrl	4.66	-	0.11	6/6	4.29	-	0.12	6/6	3.34	-	0.18	6/6
MXF	2.86^a	1.80	0.13	6/6	2.80^a	1.49	0.23	6/6	1.38^a	1.96	0.29	5/6
P-MAPA	3.72^a	0.94	0.10	6/6	3.74	0.55	0.12	6/6	2.31^a	1.03	0.12	6/6
MXF + P-MAPA	2.91^a	1.75	0.14	6/6	2.36^a	1.93	0.32	6/6	0.69^a	2.65	0.32	4/6

n = Number of mice with CFU/total number of mice at sacrifice; MXF = Moxifloxacin; SEM = standard error of the mean; log₁₀ prot = log₁₀ CFU of protection; Letter a: significantly different from Untreated Ctrl group.

Back to article page

ISSN: 1750-9378

Contact us

General enquiries: journalsubmissions@springernature.com